APA

Ellis L. A., Malangone-Monaco E., Varker H., Stetsovsky D., Kubacki M., DeHoratius R. J. & Kafka S. (2019). Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. : ClinicoEconomics and outcomes research : CEOR.

Chicago

Ellis Lorie A, Malangone-Monaco Elisabetta, Varker Helen, Stetsovsky Diana, Kubacki Maureen, DeHoratius Raphael J and Kafka Shelly. 2019. Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. : ClinicoEconomics and outcomes research : CEOR.

Harvard

Ellis L. A., Malangone-Monaco E., Varker H., Stetsovsky D., Kubacki M., DeHoratius R. J. and Kafka S. (2019). Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. : ClinicoEconomics and outcomes research : CEOR.

MLA

Ellis Lorie A, Malangone-Monaco Elisabetta, Varker Helen, Stetsovsky Diana, Kubacki Maureen, DeHoratius Raphael J and Kafka Shelly. Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. : ClinicoEconomics and outcomes research : CEOR. 2019.